Michael J. Witty
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Repositioning of a Diaminothiazole Series Confirmed to Target the Cyclin-Dependent Kinase CRK12 for Use in the Treatment of African Animal Trypanosomiasis.
Journal: Journal of medicinal chemistry
Published: March 18, 2022
Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs.
Journal: PLoS pathogens
Published: June 01, 2020
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria".
Journal: Antimicrobial agents and chemotherapy
Published: October 26, 2018
The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing.
Journal: PLoS pathogens
Published: April 12, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.
Journal: Antimicrobial agents and chemotherapy
Published: January 23, 2018
Correction to The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold.
Journal: Journal of medicinal chemistry
Published: November 23, 2017
Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT).
Journal: Bioorganic & medicinal chemistry letters
Published: September 04, 2017
The Discovery of Novel Antimalarial Aminoxadiazoles as a Promising Nonendoperoxide Scaffold.
Journal: Journal of medicinal chemistry
Published: August 15, 2017
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.
Journal: Journal of medicinal chemistry
Published: October 18, 2016
Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase.
Journal: Science translational medicine
Published: December 01, 2015
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.
Journal: Journal of medicinal chemistry
Published: October 27, 2015
Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidines.
Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidines.
Journal: Journal of medicinal chemistry
Published: September 01, 2015
Last Updated: 09/26/2026